Details of the Drug Reposition

General Information of This Drug (ID: DM5BMIO)

• Drug Name: YTB323 (DM5BMIO)
• Drug Type: CAR T Cell Therapy

Information on Drug Reposition of This Drug

2 Phase 1 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Diffuse large B-cell lymphoma	DISSACK3	2A81	Phase 1	[1]
Chronic lymphocytic leukaemia	DISEXWC3	2A82.0	Phase 1	[1]

References

• [1] ClinicalTrials.gov (NCT03960840) CD19-specific CAR-T Cells in CLL/SLL and DLBCL. U.S. National Institutes of Health.